Impact of Fingolimod Adherence on Outcomes
NCT05141669
·
clinicaltrials.gov ↗
COMPLETED
Status
694
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis
Interventions
DRUG:
Fingolimod
Sponsor
Novartis Pharmaceuticals